Blood culture contamination in the emergency department

blood culture contamination

“EDs with high blood culture contamination rates should strongly consider evidence-based strategies to reduce contamination. In addition to improving quality, implementing a sterile collection kit or phlebotomy team strategy is likely to result in net cost savings” Self et al (2014).

PICC adverse events in patients awaiting heart transplantation

totally implantable port

“We retrospectively analyzed PICC adverse events (AE) and associated cost in 129 Status 1B patients from 2005 – 2012. Endpoints were OHT, left ventricular assist device (LVAD) or death. Regression analysis was utilized to identify AE risk factors” Haglund et al (2014).

Prevention of MRSA bloodstream infections in European hospitals

peripheral IV

“Lower MRSA prevalence showed significant association with presence of incidence surveillance, performance of root cause analysis, mandatory training requirements for hand hygiene, accountability measures for persistent non-compliance, and multi-stakeholder teamwork in antibiotic prescribing” Borg et al (2014).

Impact of an educational intervention on the prevention CLABSI

hand hygiene

“In total, 508 cases of CLABSI were observed over 266,471 central line (CL)-days. At baseline, the pooled mean CLABSI rate was 2.29 per 1000 CL-days, and this decreased significantly to 1.64 per 1000 CL-days in the follow-up period” Hansen et al (2014).

Medication errors in a public hospital in Brazil

needlestick

“This article describes the analysis of the frequency, type and risk factors relating to errors in the preparation and administration of medications in patients admitted to a public hospital in Brasilia Federal District, Brazil” Renata Grou Volpe et al (2014).

A regulatory perspective of pharmaceutical compounding

vancomycin lock

“This legislation establishes a clear boundary between traditional compounders and compounding manufacturers. It clarifies a national, uniform set of rules for compounding manufacturers while preserving the states’ primary role in traditional pharmacy regulation” Timko and Crooker (2014).